<?xml version="1.0" encoding="UTF-8"?>
<p id="p0015">As SARS-Cov and SARS-CoV-2 have both emerged from China, this country has carried out more than a hundred clinical studies of this new Coronavirus infection including trials of most known antiviral drugs, antimalarial drugs, glucocorticoids, plasma therapy, virus vaccine, and certain Western drugs. Although the final results of these studies may take a long time to be completed (may be up to a year) the interim research data may be helpful for the urgent demand arising from the pandemic 
 <xref rid="b0005" ref-type="bibr">[1]</xref>. Also, Chinese herbal medicines, which are commonly used in treating viral respiratory infections, are being tested for their abilities to directly inhibit the SARS-CoV-2. The results show that of the large number of natural compounds that were screened, 13 were present in Chinese medicines. These were found to have potential for anti-2019-nCoV (SARS-CoV-2) activity 
 <xref rid="bib136" ref-type="bibr">[2]</xref>.
</p>
